Locations:
Search
Findings bolster the oral drug as an option for primary and secondary prevention
Human and animal studies show a rise in platelet reactivity, thrombosis and cardiac events
Cleveland Clinic leads pioneering assessment of the AI model for health information purposes
ACC committee underscores need to properly weigh benefits in risk-benefit calculations
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Two major trials promise key progress against the last unaddressed major risk factor
Effect on gut microbiome emerges as another benefit of statin therapy
Randomized controlled study undercuts unsubstantiated ‘heart health’ claims
Increased risk is partly mediated by microbiota-derived metabolites of L-carnitine, choline
Medicare database analysis finds reduced risk of death, heart failure, myocardial infarction and stroke
Targeted mRNA blocking could be first effective approach specific to this cardiovascular risk factor
Advertisement
Advertisement